STAAR Surgical (STAA) Reports In-Line Q4 EPS

STAAR Surgical (NASDAQ: STAA) reported Q4 EPS of $0.10, in-line with the analyst estimate of $0.10. Revenue for the quarter came in at $59 million versus the consensus estimate of $59.5 million.

For earnings history and earnings-related data on STAAR Surgical (STAA) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c